Cargando…

Safety of a 3-Step "Catch-Up Protocol” in Re-establishing Maintenance Dose Subcutaneous Immunotherapy (SCIT) Post Covid-19 Lockdown During Allergy Season.

Detalles Bibliográficos
Autores principales: Ogeer, Ijaz, Wardha, Wardha., Bhatt, Vaidehi, Wu, Vince, Hosein, Saajida, Seto, Tyler, Gyaltsen, Tenzin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Mosby, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849496/
http://dx.doi.org/10.1016/j.jaci.2020.12.048
_version_ 1783645314810380288
author Ogeer, Ijaz
Wardha, Wardha.
Bhatt, Vaidehi
Wu, Vince
Hosein, Saajida
Seto, Tyler
Gyaltsen, Tenzin
author_facet Ogeer, Ijaz
Wardha, Wardha.
Bhatt, Vaidehi
Wu, Vince
Hosein, Saajida
Seto, Tyler
Gyaltsen, Tenzin
author_sort Ogeer, Ijaz
collection PubMed
description
format Online
Article
Text
id pubmed-7849496
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Mosby, Inc.
record_format MEDLINE/PubMed
spelling pubmed-78494962021-02-02 Safety of a 3-Step "Catch-Up Protocol” in Re-establishing Maintenance Dose Subcutaneous Immunotherapy (SCIT) Post Covid-19 Lockdown During Allergy Season. Ogeer, Ijaz Wardha, Wardha. Bhatt, Vaidehi Wu, Vince Hosein, Saajida Seto, Tyler Gyaltsen, Tenzin J Allergy Clin Immunol Article Published by Mosby, Inc. 2021-02 2021-02-01 /pmc/articles/PMC7849496/ http://dx.doi.org/10.1016/j.jaci.2020.12.048 Text en Copyright © 2020 Published by Mosby, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Ogeer, Ijaz
Wardha, Wardha.
Bhatt, Vaidehi
Wu, Vince
Hosein, Saajida
Seto, Tyler
Gyaltsen, Tenzin
Safety of a 3-Step "Catch-Up Protocol” in Re-establishing Maintenance Dose Subcutaneous Immunotherapy (SCIT) Post Covid-19 Lockdown During Allergy Season.
title Safety of a 3-Step "Catch-Up Protocol” in Re-establishing Maintenance Dose Subcutaneous Immunotherapy (SCIT) Post Covid-19 Lockdown During Allergy Season.
title_full Safety of a 3-Step "Catch-Up Protocol” in Re-establishing Maintenance Dose Subcutaneous Immunotherapy (SCIT) Post Covid-19 Lockdown During Allergy Season.
title_fullStr Safety of a 3-Step "Catch-Up Protocol” in Re-establishing Maintenance Dose Subcutaneous Immunotherapy (SCIT) Post Covid-19 Lockdown During Allergy Season.
title_full_unstemmed Safety of a 3-Step "Catch-Up Protocol” in Re-establishing Maintenance Dose Subcutaneous Immunotherapy (SCIT) Post Covid-19 Lockdown During Allergy Season.
title_short Safety of a 3-Step "Catch-Up Protocol” in Re-establishing Maintenance Dose Subcutaneous Immunotherapy (SCIT) Post Covid-19 Lockdown During Allergy Season.
title_sort safety of a 3-step "catch-up protocol” in re-establishing maintenance dose subcutaneous immunotherapy (scit) post covid-19 lockdown during allergy season.
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849496/
http://dx.doi.org/10.1016/j.jaci.2020.12.048
work_keys_str_mv AT ogeerijaz safetyofa3stepcatchupprotocolinreestablishingmaintenancedosesubcutaneousimmunotherapyscitpostcovid19lockdownduringallergyseason
AT wardhawardha safetyofa3stepcatchupprotocolinreestablishingmaintenancedosesubcutaneousimmunotherapyscitpostcovid19lockdownduringallergyseason
AT bhattvaidehi safetyofa3stepcatchupprotocolinreestablishingmaintenancedosesubcutaneousimmunotherapyscitpostcovid19lockdownduringallergyseason
AT wuvince safetyofa3stepcatchupprotocolinreestablishingmaintenancedosesubcutaneousimmunotherapyscitpostcovid19lockdownduringallergyseason
AT hoseinsaajida safetyofa3stepcatchupprotocolinreestablishingmaintenancedosesubcutaneousimmunotherapyscitpostcovid19lockdownduringallergyseason
AT setotyler safetyofa3stepcatchupprotocolinreestablishingmaintenancedosesubcutaneousimmunotherapyscitpostcovid19lockdownduringallergyseason
AT gyaltsentenzin safetyofa3stepcatchupprotocolinreestablishingmaintenancedosesubcutaneousimmunotherapyscitpostcovid19lockdownduringallergyseason